Involvement of KLF4 in sulforaphane- and iberin-mediated induction of p21waf1/cip1

Nutrition and Cancer

Volumn 61, Issue 1, 2009, Pages 137-145

  Traka, Maria H ^a   Chambers, Karen F ^a   Lund, Elizabeth K ^a   Goodlad, Robert A ^b   Johnson, Ian T ^a   Mithen, Richard F ^a  

^a INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLSULPHINYL PROPY ISOTHIOCYANATE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; GROWTH HORMONE; IBERIN; KRUPPEL LIKE FACTOR 4; MARKER; RNA; SUCRASE ISOMALTASE; SULFORAPHANE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BROCCOLI; C57BL 6 MOUSE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL STRAIN CACO 2; CELL STRAIN HT29; COLON CANCER; DRUG DOSE REDUCTION; FEMALE; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STOMACH;

ANIMALS; BRASSICA; CACO-2 CELLS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENES, APC; GROWTH INHIBITORS; HT29 CELLS; HUMANS; ISOTHIOCYANATES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; SUCRASE-ISOMALTASE COMPLEX; THIOCYANATES;

BRASSICA OLERACEA VAR. ITALICA; MUS;

EID: 58149161379     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580802348641     Document Type: Article

References (50)

1. Fung T, Hu FB, Fuchs C, Giovannucci E, Hunter DJ, et al.: Major dietary patterns and the risk of colorectal cancer in women. Arch Intern Med 163, 309-314, 2003.
2. Johnson IT: Cancers of the gut and Western ills. Science 307, 1839, 2005.
3. Lin HJ, Probst-Hensch NM, Louie AD, Kau IH, Witte JS, et al.: Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 7, 647-652, 1998.
4. van Poppel G, Verhoeven DT, Verhagen H, and Goldbohm RA: Brassica vegetables and cancer prevention. Epidemiology and mechanisms. Adv Exp Med Biol 472, 159-168, 1999.
5. Juge N, Mithen RF, and Traka M: Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 64, 1105-1127, 2007.
6. Jakubikova J, Bao Y, Bodo J, and Sedlak J: Isothiocyanate iberin modulates phase II enzymes, posttranslational modification of histones and inhibits growth of Caco-2 cells by inducing apoptosis. Neoplasma 53, 463-470, 2006.
7. Jadhav U, Ezhilarasan R, Vaughn SF, Berhow MA, and Mohanam S: Iberin induces cell cycle arrest and apoptosis in human neuroblastoma cells. Int J Mol Med 19, 353-361, 2007.
8. Jakubikova J, Sedlak J, Bod'o J, and Bao Y: Effect of isothiocyanates on nuclear accumulation of NF-kappaB, Nrf2, and thioredoxin in caco-2 cells. J Agric Food Chem 54, 1656-1662, 2006.
9. Wang W, Wang S, Howie AF, Beckett GJ, Mithen R, et al.: Sulforaphane, erucin, and iberin up-regulate thioredoxin reductase 1 expression in human MCF-7 cells. J Agric Food Chem 53, 1417-1421, 2005.
10. Shen G, Xu C, Chen C, Hebbar V, and Kong AN: p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Cancer Chemother Pharmacol 57, 317-327, 2006.
11. Parnaud G, Li P, Cassar G, Rouimi P, Tulliez J, et al.: Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr Cancer 48, 198-206, 2004.
12. Jakubikova J, Sedlak J, Mithen R, and Bao Y: Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells. Biochem Pharmacol 69, 1543-1552, 2005.
13. Traka M, Gasper AV, Smith JA, Hawkey CJ, Bao Y, et al.: Transcriptome analysis of human colon Caco-2 cells exposed to sulforaphane. J Nutr 135, 1865-1872, 2005.
14. Chen X, Johns DC, Geiman DE, Marban E, Dang DT, et al.: Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J Biol Chem 276, 30423-30428, 2001.
15. Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, et al.: The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the trans-activating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem 275, 18391-18398, 2000.
16. Jenkins TD, Opitz OG, Okano J, and Rustgi AK: Transactivation of the human keratin 4 and Epstein-Barr virus ED-L2 promoters by gut-enriched Kruppel-like factor. J Biol Chem 273, 10747-10754, 1998.
17. Shields JM, Christy RJ, and Yang VW: Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem 271, 20009-20017, 1996.
18. Segre JA, Bauer C, and Fuchs E: Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet 22, 356-360, 1999.
19. Yet SF, McA'Nulty MM, Folta SC, Yen HW, Yoshizumi M, et al.: Human EZF, a Kruppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J Biol Chem 273, 1026-1031, 1998.
20. Shie JL, Chen ZY, O'Brien MJ, Pestell RG, Lee ME, et al.: Role of gut-enriched Kruppel-like factor in colonic cell growth and differentiation. Am J Physiol Gastrointest Liver Physiol 279, G806-G814, 2000.
21. Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE, et al.: Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 23, 395-402, 2004.
22. Dahlqvist A: Method for assay of intestinal disaccharidases. Anal Biochem 57, 18-25, 1964.
23. Dang DT, Mahatan CS, Dang LH, Agboola IA, and Yang VW: Expression of the gut-enriched Kruppel-like factor (Kruppel-like factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2. Oncogene 20, 4884-4890, 2001.
24. Pinto M, Robineleon S, Appay MD, Kedinger M, Triadou N, et al.: Enterocyte-like differentiation and polarization of the human-colon carcinoma cell-line Caco-2 in culture. Biol Cell 47, 323-330, 1983.
25. Grasset E, Pinto M, Dussaulx E, Zweibaum A, and Desjeux JF: Epithelial properties of human colonic carcinoma cell line Caco-2: electrical parameters. Am J Physiol 247, C260-C267, 1984.
26. Costa de Beauregard MA, Pringault E, Robine S, and Louvard D: Suppression of villin expression by antisense RNA impairs brush border assembly in polarized epithelial intestinal cells. Embo J 14, 409-421, 1995.
27. Traber PG, Yu L, Wu GD, and Judge TA: Sucrase-isomaltase gene expression along crypt-villus axis of human small intestine is regulated at level of mRNA abundance. Am J Physiol 262, G123-G130, 1992.
28. Hu R, Hebbar V, Kim BR, Chen C, Winnik B, et al.: In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J Pharmacol Exp Ther 310, 263-271, 2004.
29. Yoon HS and Yang VW: Requirement of Kruppel-like factor 4 in preventing entry into mitosis following DNA damage. J Biol Chem 279, 5035-5041, 2004.
30. Yoon HS, Chen X, and Yang VW: Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J Biol Chem 278, 2101-2105, 2003.
31. Chen ZY, Rex S, and Tseng CC: Kruppel-like factor 4 is transactivated by butyrate in colon cancer cells. J Nutr 134, 792-798, 2004.
32. Myzak MC, Karplus PA, Chung FL, and Dashwood RH: A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 64, 5767-5774, 2004.
33. Specian RD and Oliver MG: Functional biology of intestinal goblet cells. Am J Physiol 260, C183-C193, 1991.
34. Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, et al.: Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295, 1726-1729, 2002.
35. Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, et al.: The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129, 2619-2628, 2002.
36. Shibayama T, Carboni JM, and Mooseker MS: Assembly of the intestinal brush border: appearance and redistribution of microvillar core proteins in developing chick enterocytes. J Cell Biol 105, 335-344, 1987.
37. Nagase H and Nakamura Y: Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat 2, 425-434, 1993.
38. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, et al.: Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1, 229-233, 1992.
39. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, et al.: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275, 1787-1790, 1997.
40. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, et al.: Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 275, 1784-1787, 1997.
41. Stone CD, Chen ZY, and Tseng CC: Gut-enriched Kruppel-like factor regulates colonic cell growth through APC/beta-catenin pathway. FEBS Lett 530, 147-152, 2002.
42. Mahatan CS, Kaestner KH, Geiman DE, and Yang VW: Characterization of the structure and regulation of the murine gene encoding gut-enriched Kruppel-like factor (Kruppel-like factor 4). Nucleic Acids Res 27, 4562-4569, 1999.
43. Dang DT, Bachman KE, Mahatan CS, Dang LH, Giardiello FM, et al.: Decreased expression of the gut-enriched Kruppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients. FEBS Lett 476, 203-207, 2000.
44. Hu R, Khor TO, Shen G, Jeong WS, Hebbar V, et al.: Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable. Carcinogenesis 27, 2038-2046, 2006.
45. Myzak MC, Dashwood WM, Orner GA, Ho E, and Dashwood RH: Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J 20, 506-508, 2006.
46. Zhang Y, Li J, and Tang L: Cancer-preventive isothiocyanates: dichotomous modulators of oxidative stress. Free Radic Biol Med 38, 70-77, 2005.
47. Khor TO, Hu R, Shen G, Jeong WS, Hebbar V, et al.: Pharmacogenomics of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ mice. Biopharm Drug Dispos 27, 407-420, 2006.
48. Shen G, Khor TO, Hu R, Yu S, Nair S, et al.: Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in Apcmin/+ mouse. Cancer Res 67, 9937-9944, 2007.
49. Gasper AV, Al-Janobi A, Smith JA, Bacon JR, Fortun P, et al.: Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am J Clin Nutr 82, 1283-1291, 2005.
50. Hedlund TE, Maroni PD, Ferucci PG, Dayton R, Barnes S, et al.: Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in Caucasian men. J Nutr 135, 1400-1406, 2005.